HRT Financial’s Zura Bio ZURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-77,505
Closed -$461K – 5530
2026
Q1
$461K Buy
+77,505
New +$468K ﹤0.01% 2592
2025
Q3
– Sell
-32,195
Closed -$33K – 3809
2025
Q2
$33K Buy
+32,195
New +$38.5K ﹤0.01% 2356
2023
Q3
– Sell
-10,162
Closed -$83K – 3220
2023
Q2
$83K Buy
+10,162
New +$81.6K ﹤0.01% 1992
2023
Q1
– Sell
-10,412
Closed -$106K – 3309
2022
Q4
$106K Sell
10,412
-39,250
-79% -$398K ﹤0.01% 2061
2022
Q3
$499K Buy
49,662
+662
+1% +$6.62K 0.01% 1547
2022
Q2
$487K Hold
49,000
– – 0.01% 1654
2022
Q1
$485K Hold
49,000
– – ﹤0.01% 1857
2021
Q4
$483K Buy
+49,000
New +$484K ﹤0.01% 1923

Other funds holding ZURA

HRT Financial's ZURA Position: Q2 2026 in Review

HRT Financial sold out of Zura Bio (ZURA) in Q2 2026, closing a stake of 77,505 shares — an estimated $461K sold.

HRT Financial first reported a position in ZURA in Q4 2021 and held it in 8 quarters. The position peaked at $499K in Q3 2022. 95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

  • HRT Financial reported no remaining Zura Bio position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 77,505 Zura Bio shares in Q2 2026, an estimated $461K.
  • HRT Financial first reported a position in Zura Bio in Q4 2021 and held it in 8 quarters.
  • HRT Financial's Zura Bio position peaked at $499K in Q3 2022.
  • 95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.